Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could This Be the Biggest News in Treating Severe COVID So Far?


NRx Pharmaceuticals (NASDAQ: NRXP) recently reported positive results for experimental drug Zyesami in preventing cytokine storms in patients with COVID-19. In this Motley Fool Live video recorded on July 21, healthcare and cannabis bureau editor-analyst Olivia Zitkus and Motley Fool contributor Keith Speights discuss just how big NRx's news could be in treating severe COVID-19.

Continue reading


Source Fool.com

Like: 0
Share

Comments